| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |